How antimicrobial resistance is a silent pandemic
FirstpostIndia, with its scientific expertise, vibrant civil society, and rich tradition of public health innovation, can lead the global fight against antibiotic resistance. In 2017, the World Bank estimated that by 2050, unchecked AMR could wipe away 3.8 per cent of global gross domestic product each year and push 2.8 crore people into poverty. Losses resulting from the impact of drug resistance on livestock could cost global GDP up to $950 billion, while the spread of resistant pathogens from livestock to humans could cost up to $5.2 trillion due to productivity losses, increased healthcare costs, and reduced agricultural output driven by AMR. A report by the Indian Council of Medical Research in 2023 highlighted that over 70 per cent of bacterial infections in India are resistant to at least one commonly used antibiotic, making previously treatable diseases such as pneumonia, tuberculosis, and urinary tract infections far more difficult and expensive to manage.